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Background: Treatment of established depression is the dominant approach to
care of older adults, but prevention holds much promise. Self-help interventions
are a feasible preventive approach, since they are scalable and low cost. There
are few trials in this area. Behavioral Activation (BA) is a credible candidate
psychological approach, which has been shown to work in therapist led care but
not been trialled in a self-help form. Aim: To test the effectiveness of an unguided
self-help intervention based on BA for older adults. Methods: We compared a
self-help intervention based on BA for older people (n = 172) to usual care
(n = 160) in a pragmatic randomized controlled trial. Outcomes were depres-
sion status and severity (PHQ9) and health related quality of life (SF12). The pri-
mary timepoint of the primary outcome was depression at 4 months, with
longer term follow up at 12 months to test sustained impact of the primary out-
come. Results: At 4 months adjusted PHQ-9 scores for BA self-help were 0.79
lower (95% CI: -1.70 to 0.13; p = 0.09) and the proportion of participants with
case-level depression was significantly reduced (BA 31/137 (22.6%) versus usual
care 41/141 (29.1%); Odds Ratio 0.48; 95% CI: 0.26−0.92; p = 0.03). There was
no PHQ-9 difference at 12 months or for health related quality of life at any
point (4 or 12 months). Discussion: Self-help using BA for older people at risk
of depression is a feasible and scalable intervention with potential short-term
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Highlights
 What is the primary question addressed by this study?—can we treat lower severity depressive symp-
toms and prevent the onset of depression in at risk older adults using a low-technology self-help approach
based on behavioural activation.
 What is the main finding of this study?—Older people readily engaged with self-help (using bibliother-
apy) based on behavioural activation principles. There was evidence of benefit in reducing the severity and
incidence of depression in the short term, but this was not sustained at 12 months.
 What is the meaning of the finding?—Low intensity self-help interventions are a feasible intervention to
potentially mitigate short term risk of depression in older adults. Low intensity self-help interventions can
increase access to care and expansion of provision of evidence-supported models of psychological therapy.INTRODUCTION
D epression is the leading cause of mental health-related disease burden globally, affecting an
estimated 300 million people worldwide.1 By the age
of 65, one in seven older people meet formal diagnos-
tic criteria for depression (“case-level depression”).
Amongst older people, depressive syndromes often
affect people with long-term physical conditions.2
Depression worsens the outcomes of many disorders
and increases disability, hospitalization and risk of
death. The impairments in quality of life associated
with depression are comparable to those of major
physical illness.3
Less attention has been paid to those with mild
depressive disorders/sub-threshold depression syn-
dromes, or those who give positive responses to
screening questions, but do not have sufficient levels
of depressive symptoms to meet diagnostic criteria.4
Those with less severe depression and symptoms that
do not meet formal diagnostic criteria (sometimes
called “sub-clinical”, “sub-threshold” or “sub-syndro-
mal” depression) also suffer impairments in their
quality of life and level of functioning, and hold a
negative view toward aging.3 Sub-threshold depres-
sion is also a clear risk factor for progression to and
the development of more severe depressive illness.5,6
It is this population of older people with lower sever-
ity depressive symptoms who are at risk of severe
depression that is the focus of the current research.
Strategies to prevent the onset of disorders in this
group are sometimes called “indicated prevention.”7
Behavioral activation (BA) has been shown to be
effective in the treatment of depression8−10 and recentmeta-analyses show that it can be readily applied in
older adults.11,12 Our recent experience in the UK
CASPER trials of collaborative primary care13 shows
that BA is especially adaptable for use amongst older
people and can readily incorporate the problems that
cause or perpetuate depression in this population.14
For example, BA can be usefully adapted to manage
the loss of function and lack of positive reinforcement
which follows on from problems of poor mobility,
long term health problems or change in role following
retirement or bereavement.15
One way in which access to psychological thera-
pies such as BA can be enhanced is via its provision
as a low-intensity scalable self-help intervention.16,17
Guidance for depression defines self-help interven-
tions to treat depression as those which make use of a
range of books or other self-help materials derived
from an evidence-based intervention and designed
specifically for that purpose.18 There is evidence from
trials to show that self-help interventions in general
can effectively treat symptoms of depression,19,20 and
that the effectiveness of low-intensity interventions
for depression can be enhanced by the offer of sup-
port.19 However, to our knowledge there are no large
scale trials of BA self-help conducted among older
adults. The purpose of this study was to address this
evidential gap for older people with low severity
depression who are at risk of developing more severe
forms of depressive disorder.
METHODS
Study Design and Participants
The Self Help for those At Risk of Depression
(SHARD) trial was designed to examine theAm J Geriatr Psychiatry &&:&&, && 2021
Box 1 Whooley brief case-finding questions for depression
1. “Over the past month have you often been bothered by feeling
down, depressed or hopeless?”
2. “Over the past month, have you often been bothered by having
little interest or pleasure in doing things?” A positive answer to
one or both of these questions raises the possibility of depression
and necessitates a full assessment for the presence or absence of
clinically significant depressive syndrome.
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gate depression in older people in primary care who
have symptoms, but do not meet the diagnostic
threshold for clinical depression. The SHARD trial
was registered at ISRCTN95270332.
SHARD participants were identified by a screening
strategy established in primary care to form a com-
prehensive cohort of older people with all severities
of depression. The cohort has been described else-
where13 and has also been used to populate two large
scale trials of older people with case level depres-
sion21 and subthreshold depression14 (the UK CAS-
PER trials). People entered the cohort if they were
older people (aged 65 and above) who screen-positive
for depression on a brief depression questionnaire
(sometimes referred to as the “Whooley” questions
after their initial validation study),22 but who on fur-
ther assessment do not fulfil full criteria for DSM-IV
Major Depressive Disorder, and therefore have “sub-
threshold depression.”23 The Whooley questions are
detailed in Box 1.
All participants were identified by general practi-
ces: people fulfilling inclusion criteria and potentially
eligible for the SHARD trial were sent an invitation
pack (letter of invitation, Participant Information
Sheet, consent form, decline form, background infor-
mation form). Patients wishing to join the study were
asked to return completed consent and background
information forms by post to the study center. All
consenting participants were then asked to complete
a baseline questionnaire. Those who answered “yes”
to at least one Whooley question then received a diag-
nostic telephone interview. We established the pres-
ence of subthreshold depression using a criterion-
based assessment of depression according to the
American Psychiatric Association DSM-IV (estab-
lished by the validated interviewer-administered
diagnostic schedule MINI).24 Those with case-level
DSM-IV Major Depressive Disorder were offered the
opportunity to partake in a further trial of face to faceAm J Geriatr Psychiatry &&:&&, && 2021BA as part of a multi-component intervention
reported elsewhere.21
This was a primary care pragmatic trial, and we
only excluded participants if they were judged by
their general practitioner to be (1) currently experienc-
ing psychotic symptoms, (2) to have alcohol depen-
dency (as recorded on GP records), (3) to have
significant cognitive impairment or be unable to give
informed consent (4) to have experienced recent
bereavement (as recorded on GP records), (5) to have
a terminal illness, including a terminal malignancy.
Participants who were prescribed psychotropic medi-
cation were not excluded.
Intervention arm: Participants were sent a spe-
cially-designed BA self-help booklet produced for the
purposes of the SHARD trial. This booklet was enti-
tled “Helping you to maintain a positive mood in older
age: a self-help workbook” and comprised 20 printed
pages. The workbook was based on clear principles
of BA for depression.25 The core purpose of the work-
book was to introduce simple behavioral strategies
for improving mood.15 The rationale for the work-
book was to enable patients to regain functionality;
lost or reduced as part of low mood. By using princi-
ples of BA, participants were encouraged to (1) re-
establish their daily routine, (2) increase meaningful
or important activities, and (3) reduce avoidance
behaviors.
The SHARD self-help booklet was tested for read-
ability and designed after consultation with older
people with depression and their carers. After con-
senting to partake in a self-help trial, participants to
this arm of the trial were sent a copy of the self-help
booklet with an explanatory cover letter. Participants
also received a series of three telephone calls designed
to check that the materials had arrived and to offer
practical advice and encouragement to use the materi-
als (but with no advice on BA techniques or modality-
specific psychotherapeutic instructions). Calls were
offered following a 1 day training programme, and
support was from graduates with no requirement for
prior clinical experience. Calls lasting 5-10 minutes
were offered at 1 week, 3 weeks and 6 weeks follow-
ing the delivery of the self-help booklet. Support
workers were offered supervision to ensure the qual-
ity of support and adherence to the manual. In addi-
tion, all participants received the usual care of their
general practitioner and access to UK National Health
Service (NHS) primary care services.3
ARTICLE IN PRESS
Preventing Depression in At-Risk Older AdultsComparator arm: All participants in the control
group were offered usual care from their general
practitioner and access to NHS primary care services.Randomization and Masking
Simple randomization was performed using a
computer-generated random number sequence.
At the end of the baseline appointment study
researchers telephoned a secure randomization line
at the York Trials Unit and were given participant
allocation, thereby maintaining concealment of allo-
cation until after random allocation. Participants
were informed immediately. After assignment, all
outcomes were collected by self-report and all
researchers who contacted participants were blind
to treatment allocation.Outcome Measures
Primary outcome measure: the pre-specified pri-
mary outcome was depression severity and symp-
tomatology as measured on a validated self-report
measure (the Patient Health Questionnaire-9
[PHQ9])26 and the primary timepoint was 4 months.
We analysed the primary outcome of depression as a
continuous measure (PHQ-9 score) and in terms of
caseness, with caseness defined as a score of ≥10 on
the PHQ-9.27 We also measured any sustained benefit
for the primary outcome at 12 months (as a continu-
ous and dichotomous measure).
Secondary outcome measures: Health-related qual-
ity of life (measured by the SF-12 mental component
scale and physical component scale),28 at 4 and 12
months. We also measured health-state utility (Euro-
Qol - EQ5D) as part of cost per QALY health eco-
nomic analysis and this is not reported here.
Sample size calculation: We aimed to recruit 156
participants per arm. Assuming 15% attrition, the
trial had 90% power to detect at the 5% significance
level a difference of 0.4 standard deviations
(approximately 2 PHQ-9 score points) in the PHQ-9
score between the two arms. We powered our trial
on the basis of the results of a meta-analyses of the
effectiveness of self-help interventions for depres-
sion where the mean pooled effect size was 0.43
(95% CI 0.30−0.57).194
Statistical Analysis
The PHQ-9 score at 4 months was analyzed under
the intention-to-treat principle using a linear regres-
sion model adjusting for treatment allocation, gender,
age at randomization, baseline PHQ-9 score and the
physical and mental components of the SF-12 at base-
line. Covariates were pre-specified. Participants were
analysed as part of the group to which they had been
randomised (intention-to-treat) and were included in
the model if they had valid primary outcome data at
4 months, and had valid data on gender, age at ran-
domisation, baseline PHQ-9 score and the physical
and mental components of the SF-12 at baseline. The
PHQ-9 score at 12 months, and the SF-12 physical
component scale and mental component scale at 4
months and 12 months, were analyzed in the same
manner. The number of participants with a PHQ-9
score ≥ 10 (both at 4 months and 12 months) was ana-
lyzed using a logistic regression model, adjusting for
the same covariates as the primary outcome model,
and in addition adjusted for whether the PHQ-9 at
baseline was more than or equal to 10. Participants
with missing outcome and/or covariate data were
excluded from the analyses. Estimates of effect were
presented alongside corresponding 95% confidence
intervals (CI), test statistics (F-statistic and number of
degrees of freedom for linear regression; chi-squared
statistic and number of degrees of freedom for logistic
regression; t-score and number of degrees of freedom
for t test) and the p value resulting from the statistical
test. Hypothesis testing was two-sided and used a 5%
significance level. In addition, Cohen’s d was pre-
sented for the PHQ-9 score at 4 months. An unad-
justed analysis was carried out for the PHQ-9 at 4
months, using a t test. Statistical analyses were per-
formed in Stata version 15.0. In addition, we also car-
ried out a post-hoc sensitivity analysis, to assess the
impact of missing data on the analysis of the primary
outcome at 4 months. The sensitivity analysis was car-
ried out using multiple imputation by chained equa-
tions. The imputation model included the primary
and secondary outcomes at each time point, the treat-
ment group, the baseline covariates included in the
primary analysis model, and in addition any baseline
covariates that were found to be associated with the
primary outcome being missing at 4 months. The
imputation model was then used to create 100
imputed datasets, on each of which the primaryAm J Geriatr Psychiatry &&:&&, && 2021
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were then combined using Rubin’s rules to produce a
final estimate of the treatment effect, alongside a 95%
confidence interval and p-value.Ethical Approval and Role of the Funding Source
This study was undertaken as a suite of trials for
older people with depression commissioned by the
UK National Institute for Health Research (NIHR)
Health Technology Assessment Programme (project
reference HTA 10/57/43). The funder had no role in
study design, data collection, analysis or interpreta-
tion, or writing of the report. Ethical approval was
granted by NRES Committee Yorkshire & The Hum-
ber - Leeds, on 23/12/2013 (REC ref: 10/H1306/61).
The corresponding author had full access to all the
data in the study and had final responsibility for the
decision to submit for publication.
RESULTS
A total of 332 participants were randomized to the
two-armed comparison of BA self-help booklet versus
usual care, n = 172 and n = 160 respectively. The first
permission to contact was received on February 14,
2014, and the first participant was randomized on
March 10, 2014. The final participant was randomized
on August 11, 2014. The flow of participants through
the trial is shown in the CONSORT diagram (Fig. 1).
The treatment groups were well-balanced in terms
of age and gender, and we noted high levels of con-
current long-term physical conditions. The commonly
reported comorbidities being hypertension and heart
disease, osteoarthritis, respiratory, and eye condi-
tions. One fifth of participants (68/332, 20.5%) were
prescribed antidepressant medication (BA self-help
37/172, 21.5%; usual care 31/160, 19.4%). There
were baseline imbalances in levels of depression
despite randomization (mean PHQ scores: BA self-
help mean score 8.6, SD = 4.6; usual care mean score
7.7, SD = 4.2), and these were adjusted for in the
between group comparisons as part of the pre-
planned statistical analysis. Retention rates at 4
months were 145 (84.3%) for BA self-help and 148
(92.5%) for usual care. At 12 months retention rates
were 140 (81.4%) for BA self-help and 139 (86.9%) for
usual care. Table 1Am J Geriatr Psychiatry &&:&&, && 2021PHQ-9 score: At the 4 month primary outcome
time point the adjusted between-group difference in
PHQ-9 scores was 0.79 points (95% CI: -1.70 to 0.13; F
(1, 271) = 2.85; p = 0.09) in favor of BA self-help, with
a Cohen’s d of -0.17 (95% CI: -0.41 to 0.06; F(1,
271) = 2.85; p = 0.09). At 12 months there was no lon-
ger evidence of a between-group difference in PHQ-9
scores (adjusted mean difference 0.15 ;95%: CI -0.95 to
1.25; F(1, 257) = 0.07; p = 0.79).
Depression “caseness” using PHQ-9 as a dichoto-
mous outcome: After 4 months 31/137 (22.6%) of the
participants in the BA self-help and 41/141 (29.1%) of
the usual care group had a PHQ-9 score greater than
or equal to 10. The odds of being depressed (defined
as PHQ-9 ≥10) at 4 months were reduced by half in
the BA self-help group compared to usual care
(adjusted odds ratio [OR] 0.48; 95% CI: 0.26 to 0.92;
x2(1) = 4.89; p = 0.03). There was no sustained evi-
dence of benefit of BA self-help at 12 months
([adjusted OR 1.56; 95% CI: 0.88 to 2.77; x2(1) = 2.27;
p = 0.13) (Table 2).
Health related quality of life: we found no differen-
ces in health related quality of life as measured by the
SF12 in either the physical or mental health compo-
nent scores at 4 or 12 months (Table 2). Post-hoc sen-
sitivity analysis: Using multiple imputation by
chained equations, the adjusted mean difference in
the PHQ-9 score at 4 months was -0.82 points (95%
CI: -1.71 to 0.08; p=0.07) and the adjusted odds ratio
for depression ‘caseness’ using the PHQ-9 as a
dichotomous outcome at 4 months was 0.53 (95% CI:
0.29 to 0.96; p=0.04).DISCUSSION
The main finding of the SHARD trial is that a brief
minimally supported form of BA self-help via a work-
book (sometimes called bibliotherapy) was poten-
tially effective at our 4 month primary outcome point
in preventing case level depression as measured by
the PHQ-9. The odds of developing depression in this
at risk population were halved at 4 months, and this
was statistically significant. The size of effect was in
line with previous estimates, but we could not
exclude the possibility that the results were by chance
since by continuous measure of the PHQ9. The effect
had attenuated by 12 months, and we also found no5
FIGURE 1. Consolidated standards of reporting trials (CONSORT) diagram.
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TABLE 1. Baseline Characteristics of Randomized Participants










n (%) 170 (98.8) 159 (99.4) 137 (100) 141 (100)
Mean (SD) 74.9 (6.7) 73.9 (6.7) 74.2 (6.5) 73.8 (6.7)
Median (IQR) 73.8 (69.0, 79.9) 72.3 (68.2, 78.2) 72.6 (68.6, 79.4) 72.0 (68.0, 77.6)
Min, Max 65.3, 91.1 65.7, 92.1 65.3, 90.2 65.7, 92.1
Gender, n (%)
Male 70 (40.7) 72 (45.0) 58 (42.3) 66 (46.8)
Female 99 (57.6) 84 (52.5) 79 (57.7) 75 (53.2)
Missing 3 (1.7) 4 (2.5) 0 (0) 0 (0)
Continued education after school leaving age, n (%)
Yes 93 (54.1) 87 (54.4) 76 (55.5) 81 (57.4)
No 77 (44.8) 70 (43.8) 61 (44.5) 58 (41.1)
Missing 2 (1.2) 3 (1.9) 0 (0) 2 (1.4)
Smoker, n (%)
Yes 15 (8.7) 11 (6.9) 13 (9.5) 10 (7.1)
No 153 (89.0) 143 (89.4) 122 (89.1) 127 (90.1)
Don’t know 0 (0) 3 (1.9) 0 (0) 2 (1.4)
Missing 4 (2.3) 3 (1.9) 2 (1.5) 2 (1.4)
Ethnicity, n (%)
White 167 (97.1) 157 (98.1) 134 (97.8) 139 (98.6)
Other 0 (0) 1 (0.6) 0 (0) 1 (0.7)
Missing 5 (2.9) 2 (1.3) 3 (2.2) 1 (0.7)
Number of health problems, n (%)
0 11 (6.4) 11 (6.9) 9 (6.6) 7 (5.0)
1 44 (25.6) 26 (16.3) 38 (27.7) 26 (18.4)
2 44 (25.6) 44 (27.5) 35 (25.5) 40 (28.4)
3+ 71 (41.3) 78 (48.8) 55 (40.1) 68 (48.2)
Missing 2 (1.2) 1 (0.6) 0 (0) 0 (0)
Health problems, n (%)
Diabetes 29 (16.9) 40 (25.0) 22 (16.1) 34 (24.1)
Osteoporosis 17 (9.9) 14 (8.8) 13 (9.5) 10 (7.1)
High blood 72 (41.9) 84 (52.5) 52 (38.0) 74 (52.5)
pressure
Rheumatoid 19 (11.0) 26 (16.3) 13 (9.5) 22 (15.6)
arthritis
Osteoarthritis 51 (29.7) 49 (30.6) 42 (30.7) 42 (29.8)
Stroke 9 (5.2) 8 (5.0) 7 (5.1) 7 (5.0)
Cancer 17 (9.9) 23 (14.4) 14 (10.2) 22 (15.6)
Respiratory 36 (20.9) 52 (32.5) 30 (21.9) 49 (34.8)
conditions
Eye condition 46 (26.7) 45 (28.1) 39 (28.5) 39 (27.7)
Heart disease 52 (30.2) 42 (26.3) 40 (29.2) 35 (24.8)
Other 50 (29.1) 43 (26.9) 43 (31.4) 40 (28.4)
PHQ-9 Score
n (%) 172 (100) 160 (100) 137 (100) 141 (100)
Mean (SD) 8.6 (4.6) 7.7 (4.2) 8.5 (4.6) 7.5 (4.2)
Median (IQR) 8 (5, 11.5) 7 (4, 10) 8 (5, 11) 7 (4, 10)
Min, Max 0, 25 0, 20 0, 25 0, 20
Whooley Question 1, n (%)
Yes 147 (85.5) 125 (78.1) 115 (83.9) 110 (78.0)
No 25 (14.5) 35 (21.9) 22 (16.1) 31 (22.0)
Whooley Question 2, n (%)
Yes 120 (69.8) 102 (63.8) 97 (70.8) 89 (63.1)
No 52 (30.2) 58 (36.2) 40 (29.2) 52 (36.9)
Self-reported use of any antidepressant medication, n (%)
Yes 37 (21.5) 31 (19.4) 30 (21.9) 30 (21.3)
No 108 (62.8) 100 (62.5) 86 (62.8) 87 (61.7)
Don’t know 1 (0.6) 4 (2.5) 1 (0.7) 3 (2.1)
Missing 26 (15.1) 25 (15.6) 20 (14.6) 21 (14.9)
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TABLE 2. Depression (PHQ-9) and Health Related Quality of Life (SF12) at Each Time Point
BA Self-Help Usual care
No. in Model Mean (95% CI) No. in Model Mean (95% CI)
Mean Difference
(95% CI)F(df1, df2)/t(df) p value
PHQ-9 Score
Primary [adjusted]
Month 4 137 6.81 (6.16, 7.46) 141 7.59 (6.95, 8.23) -0.79 (-1.70, 0.13)
F(1, 271) = 2.85
0.09
Month 12 133 7.18 (6.41, 7.95) 131 7.03
(6.25, 7.80)
0.15 (-0.95, 1.25)
F(1, 257) = 0.07
0.79
Unadjusted
Month 4 144 7.07 (6.41, 7.73) 147 7.38 (6.58, 8.18) -0.31(-1.34, 0.72)
t(289) = 0.59
0.55






























Month 4 131 38.77 (37.46, 40.07) 138 38.36 (37.09, 39.64) 0.40 (-1.43, 2.23)
F(1, 262) = 0.19
0.67
Month 12 125 38.42 (37.00, 39.84) 126 36.99 (35.57, 38.41) 1.43 (-0.59, 3.45)
F(1, 244) = 1.95
0.16
SF-12 MCS [adjusted]
Month 4 131 44.59 (43.13, 46.04) 138 44.26 (42.84, 45.68) 0.33 (-1.71, 2.37)
F(1, 262) = 0.10
0.75
Month 12 125 45.16(43.49, 46.84) 126 46.36 (44.69, 48.02) -1.19 (-3.56, 1.18)
F(1, 244) = 0.98
0.32
Notes: PCS: physical component scale; MCS: mental component scale.
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ity of life at any point.Strengths of the SHARD Trial
SHARD is one of the largest trials of unguided self-
help undertaken to date. In addition, to our knowl-
edge, this is the first self-help trial undertaken in a
population of older adults using BA (an intervention
previously shown to be effective in face to face deliv-
ery and in case level depression).12,29 The SHARD
trial adds to emerging evidence of the potential for
indicated prevention in depression30 and extends this
evidence to include older adults. We used a prag-
matic design and there were few exclusion criteria.
We recruited in primary care and achieved the
planned sample size. SHARD participants had high8
levels of multi-morbidity in line with the prevalence
of long-term conditions for older people, the impact
of ill health on psychological health.31 This is helpful
in judging the external validity and applicability of
the results to the large population of older people
with subthreshold symptoms. In most healthcare set-
tings such patients receive little or no care for psycho-
logical symptoms and their heightened risk of
developing more severe disorders. We also included
a long period of follow up (with high follow up rates)
and this is helpful in establishing what the maximal
effect for a low intensity interventions are in the short
term. The SHARD study demonstrates a modest clini-
cal effect and this was achieved with minimal inter-
vention. The support calls were brief and focused on
encouragement to use the booklet, with no require-
ment for skilled psychotherapeutic support. As suchAm J Geriatr Psychiatry &&:&&, && 2021
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approach for those at risk of major depression and
adds to an emerging evidence base for this approach
in older adults, including those in lower resource
countries,32 and underserved populations.33Limitations of the SHARD Trial
We identify three limitations. First, though we
achieved high levels of follow up, there was differen-
tial attrition between arms (retention 84.3% for BA
self-help and 92.5% for usual care at 4 months). This
has the potential to bias the results in either direction,
and the results of the trial must be interpreted with
some caution. However, the post-hoc sensitivity anal-
ysis we carried out gave similar results to the primary
analysis. Second, this was a test of the ability of a
low-intensity intervention to prevent the occurrence
of case level depression at 4 months and the design
could have been enhanced with the application of a
criterion-referenced diagnostic interview to judge the
presence of depression. However we used an instru-
ment with established diagnostic properties as a
proxy27,34 and the PHQ9 has now been adopted as a
global standard measure by the NIMH and the Well-
come Trust.35 We also minimized observer bias by
the use of masking and participant self-report of the
primary outcome measure. Third, though this was a
large trial compared to the existing trials literature,
we were still underpowered to detect a small effect in
line with other estimates from self help interventions.
Our primary endpoint of a continuous measure of
depression severity might therefore have not been
able to detect a difference if one existed at 3 months
and at 12 months. The interpretation of confidence
interval estimates and p values should therefore also
consider possible type II errors.Implications and Need for Further Research
BA is a form of psychological therapy with an estab-
lished efficacy in working age10 and older adult popu-
lations with depression.12 However, the capacity to
extend treatments to people with subthreshold depres-
sion is always going to be limited by health services
resources. By identifying a minimal intervention that is
likely to be effective in mitigating symptoms in the
short term, there is scope to integrate such treatments
at low cost and with high levels of patient access.16Am J Geriatr Psychiatry &&:&&, && 2021We also note trends in the development and evolu-
tion of self-help interventions over recent years.36
There is now a movement towards the offer of struc-
tured forms of psychological therapy as a form of
self-help, delivered via the internet or via digital tech-
nology. Previous trials (and meta-analyses of trials)
have shown some evidence of effect for guided digital
interventions,37 whilst pragmatic trials have demon-
strated minimal effect and lower levels of uptake.38
There are concerns that the shift to digital delivery of
self-help interventions may inadvertently exclude cer-
tain sections of the population and widen inequalities
in treatment and access. The “digital divide” is a par-
ticular issue for lower-income populations and for
older people39 and we deliberately chose a low tech-
nology form of self-help in the form of bibliotherapy
based around BA principles to minimize barriers to
access. The provision of self-help materials such as
those used in the SHARD trial could form a first treat-
ment offer in a stepped care approach40 for older peo-
ple with low severity depressive symptoms or at risk
of depression.
The results of the SHARD trial also raise the pos-
sibility of preventing the onset of depression in
populations at risk by reason of pre-existing symp-
toms. This approach aligns with the strategy of
“indicated prevention” under the classification of
preventative strategies offered by the Institute of
Medicine.7 The results of the SHARD trial should
be viewed alongside other positive trials of BA and
collaborative care in preventing the onset of depres-
sion in older people with subthreshold depres-
sion.14 There is also accumulating evidence for the
role of structured psychological therapies in preven-
tion,41 but the SHARD trial is one of only a small
number of trials of a self-help intervention in an
indicated risk population.42
Finally, we note that the support offered along-
side BA was minimal and only involved three infor-
mation-giving phone calls from a person without
extensive clinical experience and following only
brief training. There is trial-based evidence that the
effectiveness of bibliotherapy self-help is enhanced
with greater levels of support.17 This raises the pos-
sibility that the effect could have been larger or
more durable with a greater level of support or sup-
port delivered over a longer period. More research
is needed to explore the additional benefits of
greater levels of support.9
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